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Edited by Robert BaroukiAbstract During sepsis, microbial derived products (‘‘pathogen-
associated molecular patterns’’, PAMPs) are recognized as
exogenous danger signals by speciﬁc sensors of the host (‘‘pat-
tern recognitions receptors’’, PRRs). This interaction leads to
the release of numerous stress proteins that are a prerequisite
to ﬁght infection, though their overzealous production can con-
tribute to tissue damage, organ dysfunction and eventually death.
In critically ill patients, translocation of PAMPs can occur from
the gut, and injured tissues and cells release endogenous danger
signals called ‘‘alarmins’’ (e.g. High mobility group box-1);
that share some properties with PAMPs. Thus, numerous simi-
larities occur during infectious and non-infectious systemic
inﬂammation.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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During sepsis, a cascade of events is initiated by microorgan-
isms and their derived products called ‘‘pathogen-associated
molecular patterns’’ (PAMPs). These molecules are common
to pathogenic, non-pathogenic, and commensal bacteria, mak-
ing ‘‘microbial-associated molecular patterns’’ (MAMPs) a
more appropriate term than PAMPs. They include surface
molecules such as endotoxin (e.g. lipopolysaccharide, LPS;
lipoproteins; outer-membrane proteins; ﬂagellin; ﬁmbriae;
peptidoglycan, PGN; peptidoglycan-associated lipoprotein;
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DNA fragments). MAMPs are recognized by speciﬁc ‘‘pattern
recognition receptors’’ (PRRs). In the host, Toll-like receptors
(TLR) and cytoplasmic PRRs (e.g. NOD1 and NOD2) act as
sensors of the MAMPs, recognized as exogenous danger sig-
nals. Within tissues, cells are exposed to more than one single
signal, and multiple stimuli act in synergy leading to an en-
hanced production of inﬂammatory cytokines (Fig. 1). For
example, a synergy has been reported between endotoxin and
other microbial TLR agonists or Nod ligands, Gram-posi-
tive-derived exotoxins, viral infection, hypoxia, or simply
glucose. Similarly, inﬂammatory cytokines (e.g. gamma-
interferon, IFNc; granulocyte–macrophage colony stimulating
factor, GM-CSF; and tumor necrosis factor, TNF), inﬂamma-
tory mediators (e.g. platelet-activating factor, PAF; substance
P) further increase the LPS-induced macrophage activity and
the LPS-induced lethality. Complement activation leading to
anaphylatoxin C5a, or coagulation activation leading to
thrombin further amplify cytokine expression. In most cases,
these synergies lead to more severe organ failure.
Cytokines play a major role in orchestrating the anti-infec-
tious process. Cytokines further enhance the microbicidal
activities of phagocyting cells, contribute to the recruitment
of leukocytes towards the site of infection, enhance hematopoi-
esis, and induce fever. Their production is very fast after the
insult as illustrated by the TNF peak, only 1:30 h after injec-
tion of endotoxin. Many cells, including leukocytes, epithelial
cells, endothelial cells contribute to these productions. Mast
cells contain pre-formed cytokines, favoring a very rapid
release of active molecules. While inﬂammatory cytokines
contribute to the anti-infectious process, their excessive pro-
duction has severe side eﬀects. Anti-inﬂammatory cytokines
are also produced in large amounts during sepsis. While their
role is to dampen the inﬂammatory events, their excessive pro-
duction may favor the immunodepression observed in sepsis.
All these cytokines are part of a complex network of inter-
actions and are integrated elements of the sepsis puzzle.
Non-infectious systemic inﬂammatory response syndrome
(SIRS) shares many common parameters with sepsis. Critically
ill patients in intensive care units (ICU) (e.g. resuscitated pa-
tients after cardiac arrest, vascular and abdominal surgery,
trauma, burns. . .) undergo an inﬂammatory process that can
lead to organ dysfunction and eventually death with patho-
physiological events similar to those seen in sepsis. Matzinger
revolutionized the deﬁnition of immunity by hypothesizing
that immune system activity stemmed from recognition of
and reaction to internal danger signals, rather than from dis-
crimination between self and non-self molecules [1]. Mostblished by Elsevier B.V. All rights reserved.
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Fig. 1. Concomitant signals act synergistically. During an infectious process host’s leukocytes (e.g. macrophages) are responding to exogenous
danger signals that are the pathogens-associated molecular patterns (PAMPs). The response is ampliﬁed by endogenous mediators released during
the anti-infectious response and by co-factors or concomitant stressful events, including endogenous danger signals (alarmins) or iatrogenic events.
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internal danger signals generated by tissue injury (e.g. necrotic
cells; released RNA; crystals of uric acid; high mobility group
box-1, HMGB-1). The term ‘‘alarmin’’ has recently been pro-
posed by Oppenheim to characterize such endogenous stress
molecules that signal tissue and cell damage [2]. The possible
translocation of endoxin from hypoxic gut can also contribute
to the similar features that exist between sepsis and various
SIRS.2. Bio-markers of stress in plasma
2.1. Half-angel – half devil cytokines
During these last 20 years, the role of inﬂammatory cyto-
kines to protect against infection has been well established in
animal models. The diﬀerent approaches included injection
of recombinant pro-inﬂammatory cytokines, particularly
TNF, interleukin-1 (IL-1), and IFNc, injection of neutralizing
antibodies directed against these cytokines, and the use of
cytokine- or cytokine receptor-deﬁcient mice. In humans, the
altered capacity to produce IL-1 was associated with recurrent
infections [3]. In the mean time, other models deﬁnitively dem-
onstrated that lethal toxic shocks or lethal infections were due
to the same cytokines, particularly TNF, IL-1b, IL-12, IL-18,
IFNc, GM-CSF, macrophage migration inhibitory factor
(MIF), and IFNb (Table 1). The lethality consecutive to the
injection of endotoxin or superantigen, together with galactos-
amine, a hepatotoxic agent, was prevented in TNF receptordeﬁcient mice [4]. However, it is worth noting that in the ab-
sence of galactosamine, similar amounts of LPS are required
to kill TNF knock-out mice and normal mice [5]. On the other
hand, anti-TNF treatments have been shown to be highly eﬃ-
cient in protecting animals against endotoxic shock and lethal
bacteraemia. Such treatments also protected against pulmon-
ary microvascular injury after intestinal ischemia injury, which
is associated with endotoxin translocation [6].
IL-1b converting enzyme (ICE) or caspase-1 is the enzyme
required for the maturation of the 30 kDa biologically-inac-
tive IL-1b precursor to the mature 17 kDa active form of
IL-1b. Interleukin-1b deﬁcient mice are normally sensitive
to the lethal eﬀect of LPS, but the survival to a lethal dose
of endotoxin reaches 70% among caspase-1-deﬁcient animals
[7]. These results most probably reﬂect the involvement of
caspase-1 in the maturation of IL-18, another member of
the IL-1 family. While IL-18 promotes healing from bacterial
infection in mice, it accounts for both TNF and Fas Ligand-
mediated hepatotoxicity in endotoxin-induced liver injury [8].
Neutralization of IL-18 protected mice against lethal Esche-
richia coli or Salmonella typhimurium endotoxemia [9] and
IL-18 deﬁcient mice showed decreased sensitivity towards
LPS-induced shock [10]. IL-18 favors IFNc production. In
a cecal ligation and puncture (CLP) model of peritonitis,
Echtenacher et al. [11] showed that concomitant injection of
IFNc further increased lethality. Similarly, a deleterious eﬀect
of IFNc was demonstrated as anti-IFNc treatment increased
survival in a lethal infection with Staphylococcus aureus
[12].
Table 1
Immune dysregulation during sepsis and SIRS is characterized by an exacerbated production of pro-inﬂammatory mediators that can lead to tissue
injury and eventual lethality
Mediators that can contribute to tissue injury, organ or system dysfunction, and eventual lethalitya
Cytokines Tumor necrosis factor (TNF)
Interleukin-1 (IL-1)
IL-2
IL-12
IL-15
IL-18
IL-27
Gamma interferon (IFNc)
IFNb
Granulocyte–macrophage colony-stimulating factor (GM-CSF)
Leukemia Inhibitory factor (LIF)
Macrophage migration inhibitory factor (MIF)
Some chemokines
CXCL8 (IL-8)
CCL5
CXCR1 and 2 ligands
CCR1 ligands
CCR4 ligandsb
Growth factors Vascular endothelial growth factor (VEGF)
Cell markers of stress High Mobility Group Box-1 protein (HMGB-1)
Crystal of uric acid
S100
Plasma factors Ligand of Triggering receptor expressed on myeloid cells-1 (TREM-1)
Anaphylatoxin C5a
Mannose-binding lectin (MBL)
Lipid Mediators Prostaglandins
Leukotrienes
Platelet activating factor (PAF)
Oxidized phospholipids
Purine nucleoside adenosine (via A2A receptor)
Neuromediators Substance P
Noradrenalin
Enzymes Cyclo-oxygenase-2 (COX2)
5-Lipoxygenase
Phospholipase A2
Mast cell dipeptidyl peptidase I
Elastase
Glycogen synthase kinase-3 (GSK-3)
Inducible nitrite oxide synthase (iNOS)
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
Coagulation factor Tissue factor
Thrombin
Free radicals NO
O2
aAs demonstrated in animal models with the help of speciﬁc antibodies, inhibitors or antagonists, or with knockout mice.
bEither CCL17 or CCL22.
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fore detectable in blood, where they are normally absent. How-
ever, the circulating cytokines are merely the tip of the iceberg
[13], and cell-associated cytokines can be shown even when
plasma levels are undetectable. Among cytokines, IL-6 is prob-
ably the best marker of the severity of infectious or non-infec-
tious stress. IL-6 induces a broad array of acute-phase proteins
that limit inﬂammation, such as a-1-acid-glycoprotein or C-
reactive protein. More recently, IL-1 receptor antagonist (IL-
1Ra), LPS binding protein (LBP), and soluble CD14 wereidentiﬁed as acute-phase proteins. However, IL-6 may induce
myocardial depression during septic shock, as shown during
meningococcemia [14].
2.2. Inﬂammatory mediators
Sepsis is associated with increased plasma levels of histamine
from mast cells and basophils following activation of comple-
ment pathways with up-regulation of anaphylatoxins C3a and
C5a. Exogenous histamine or selective histamine H2 recep-
tor agonist protect against endotoxin shock. Anaphylatoxins
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and are chemo-attractants for leukocytes. When compared to
wild-type mice, C5-deﬁcient mice respond to LPS by lower
TNF levels and a lower severity index, and anti-C5a or anti-
C5a receptor antibodies prevent death from sepsis. In contrast,
knock-out mice for C4, C3, and C3 receptor are more suscep-
tible to endotoxin, and C1 inhibitor confers protection against
death from sepsis.
Pro-inﬂammatory cytokines induce synthesis of phospholi-
pase A2, inducible cyclo-oxygenase (COX-2), 5-lipoxygenase,
and acetyltransferase, which contribute to the synthesis
of eicosanoids (prostaglandins and leukotrienes) and plate-
let-activating factor (PAF). These lipid mediators, acting
through speciﬁc G-protein-coupled receptors, promote inﬂa-
mmation, altering vasomotor tone and increasing blood ﬂow
and vascular permeability. Mice deﬁcient in phospholipase
A2 receptor, or COX-2, or 5-lipoxygenase, are more resistant
to endotoxin. However, prostaglandins E2 have also the
property to reduce TNF production. A deleterious role has
also been attributed to adenosine, an endogenous purine
nucleoside that has been shown to contribute to the
alteration of the immune status of septic patients, while the
inactivation of its receptor (A2A) increases survival in polymi-
crobial sepsis [15].
Produced by NADPH oxidase, superoxide anion oxidizes
and alters proteins and unsaturated fatty acids of phospholip-
ids. However, some oxidized phospholipids can prevent endo-
toxin-induced inﬂammation by blocking the interaction
between LPS and LBP or CD14. Knock-out mice for NADPH
oxidase compounds are more susceptible to severe infections,
although their sensitivity to endotoxin remains unaltered. Mice
deﬁcient in inducible nitric oxide synthase (iNOS) merely
exhibit less severe hypotension following lethal endotoxin chal-
lenge. In patients, NO is released in large amounts following
endotoxin exposure and cytokine-related stimulation of iNOS
activity within inﬂamed tissues and vessel walls [16]. This NO
excess contributes to the development of microvessel damage,
vascular hyporeactivity, and organ dysfunction, probably by
inducing apoptosis.
Neuro-mediators play a major role in controlling inﬂamma-
tion. Substance P increases cytokine production, histamine
release, leukocyte adhesion, chemotaxis, and vascular perme-
ability. Catecholamines diversely interfere with cytokine pro-
duction. Noradrenaline, via the a2-adrenergic receptor,
increases TNF production, whereas adrenaline interaction
with the b2-adrenergic receptor decreases TNF production
in vitro and in vivo in LPS-challenged healthy volunteers,
and concomitantly enhances IL-10 production. In addition,
adrenaline increases IL-8 production and suppresses NO
production. The anti-inﬂammatory eﬀects of b-agonists are
mediated through reduced IjBa degradation and through
increased intracellular cAMP levels. Vasoactive intestinal pep-
tide and pituitary adenylate cyclase-activating peptide are two
anti-inﬂammatory neuropeptides that inhibit cytokine pro-
duction and protect mice from LPS lethality. In LPS-treated
rats, vagal nerve stimulation attenuates hypotension and
reduces plasma- and liver-TNF levels through an interaction
between acetylcholine and the a7 subunit of the nicotinic
receptor at the macrophage surface [17]. Finally, a-melano-
cyte stimulating hormone, is another neuro-mediator that
dampens inﬂammation by inhibiting pro-inﬂammatory cyto-
kine production.Cross-talk between cytokines and neuro-hormones is the
cornerstone of homeostasis restoration during stress. The pro-
duction and release of vasopressin and corticotropin-releasing
hormone are enhanced by circulating TNFa, IL-1, IL-6, and
IL-2, by locally expressed IL-1b and NO, and by aﬀerent vagal
ﬁbers. Moreover, cortisol synthesis is modulated by locally ex-
pressed IL-6 and TNFa. Up-regulated hormones help to main-
tain cardiovascular homeostasis and cellular metabolism and
to wall-oﬀ foci of inﬂammation. Impaired endocrine responses
to sepsis may result from cytokines, neuronal apoptosis,
metabolic and ischemic derangements in the hypothalamic–
pituitary and adrenal glands, and drug administration. Deﬁ-
ciencies in adrenal gland function and vasopressin production
may occur in about one-half and one-third, respectively, of
septic shock cases, contributing to hypotension and death.2.3. Soluble membrane markers
Host serum contains several proteins that have been shown
to interact with LPS. These proteins create a sensitive recogni-
tion system that allows the detection of trace amounts of this
bacterial compound. Some of these proteins are present at
homeostasis (such as sCD14), but their levels are considerably
increased during sepsis [18]. Depending on their concentra-
tion, these LPS-binding molecules may facilitate LPS interac-
tion with Toll-like receptor 4 (TLR4)-bearing cells, or on the
contrary decrease cellular response. As an example, sCD14
has been shown to favor the response of cells devoid of mem-
brane CD14, such as endothelial and some epithelial cells. In
contrast, high levels of sCD14 compete with the membrane
form present on monocytes, and inhibit monocyte response
to LPS by transferring cell-bound LPS to plasma lipoproteins
[18]. Thus, sCD14 reduces the ability of monocytes to produce
cytokines in response to LPS, whereas, at the same time, it
may enhance the response of endothelial or epithelial cells.
The concentration of circulating sCD14 is modiﬁed not only
during infection, but also after a major stress, such as trauma
or surgery. Indeed, sCD14 concentration was found to in-
crease postoperatively in patients undergoing surgery or after
trauma. In addition to the blood compartment, an increase of
sCD14 may be observed in the lungs of patients undergoing
inﬂammatory or infectious processes. This is the case after
acute respiratory distress syndrome (ARDS), sarcoidosis or
tuberculosis.
The triggering receptor expressed on myeloid cells-1
(TREM-1) was originally described as a cell surface receptor
selectively expressed on monocytes/macrophages and neutro-
phils (see below). Clinical studies reported that this molecule
is present as a soluble form. Much interest was put on the lat-
ter form because it was found to be increased in the plasma of
septic patients and in the bronchoalveolar lavage ﬂuids of pa-
tients diagnosed with pneumonia [19]. sTREM-1 was thus con-
sidered to be a new and speciﬁc marker of infection. However,
more recently, an increase of sTREM-1 was reported in the ab-
sence of infection, in the gastric juice of patients with peptic ul-
cer disease, and in pleural eﬀusion in patients with neoplastic
disorders [20,21]. Similarly, we were able to show high levels
of sTREM-1 in the plasma of patients after surgical stress or
ischemia-reperfusion [22]. Our study included two groups of
patients without infection but with severe inﬂammation: elec-
tive heart surgery and patients resuscitated after cardiac arrest.
In the cardiac arrest patients with refractory shock, sTREM-1
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The increase of circulating sTREM-1 in non-infectious severe
inﬂammation is probably due to bacterial translocation from
the gut. It has been shown that the injection of LPS to healthy
volunteers results in an increase of circulating sTREM-1 [23],
and circulating endotoxin was detected in the plasma of many
resuscitated cardiac arrest patients [24]. Thus, similarly to
other molecules that were ﬁrst thought to be speciﬁc to infec-
tion, e.g. procalcitonin or C-reactive protein, circulating
sTREM-1 seems to be a marker of severe inﬂammation rather
than infection.
Soluble forms of pattern recognition receptors or associated
proteins may also be detected in human ﬂuids. This is the case
for soluble Toll-like receptor 2 (sTLR2). TLR2 belongs to a
family of trans-membrane PPRs sensing bacterial products.
TLR2 has been shown to sense bacterial lipoproteins, LTA
[25], and eventually peptidoglycan although this latter prop-
erty remains controversial. Soluble TLR2 was detected in hu-
man breast milk, saliva and serum. The biological role of this
soluble receptor is not clear. It is thought that it may interfere
and inhibit the binding of TLR2 ligands to the membrane form
of this receptor and thus inhibit cell activation. The level of
sTLR2 was found to be decreased in some pathologies such
as tuberculosis and acute myocardial infarction, but there is
no information about sTLR2 levels during sepsis. MD-2 is a
soluble protein that is associated with TLR4 to form the recep-
tor for LPS. MD-2 has been shown to be essential for TLR4
transfer from the Golgi apparatus to cell surface and a prere-
quisite for LPS sensing. Soluble MD-2 has been detected in the
plasma of patients with severe sepsis or septic shock, and in
lung edema ﬂuids from patients with ARDS [26]. Similarly
to sCD14, sMD-2 may enhance the reactivity of TLR4-posi-
tive epithelial cells towards LPS, whereas it would down-regu-
late the reactivity of cells positive for both TLR4 and MD-2,
such as monocytes.
E-selectin, vascular cell adhesion molecule (VCAM)-1 and
intercellular adhesion molecule (ICAM)-1 are expressed on
vascular endothelium. They are key molecules for leukocyte
recruitment within the tissues. E-selectin is important for the
rolling phase on vascular endothelium, and ICAM-1 and
VCAM-1 are necessary for ﬁrm adhesion. The expression of
E-selectin and ICAM-1 on endothelial cells is increased upon
activation by cytokines or endotoxin. This increased expres-
sion leads to a massive recruitment of neutrophils and proba-
bly contributes to tissue damage and organ failure. In a mouse
model of CLP an increase of ICAM-1 on lung endothelial cells
has been shown [27]. More generally, infection and some
inﬂammatory pathologies are associated with an increase of
the soluble forms of these molecules. The mechanism of this
induction is unclear, they are probably the result of membrane
shedding after proteolytic cleavage. The precise role of these
soluble molecules is also unknown. They may be induced to
counteract the massive adhesion and recruitment of leukocytes
on endothelial cells. However, the production of these soluble
forms seems to be delayed as compared to their increased
expression on endothelium. As an example, the maximum
expression of ICAM-1 on lung endothelial cells is obtained
6 h post-CLP, whereas a signiﬁcant increase of sICAM-1 in
the plasma is only seen after 18 h [27]. Nevertheless, the levels
of sE-selectin, sVCAM-1 and sICAM-1 are signiﬁcantly in-
creased during human sepsis and correlate with severity, multi-
ple organ failure and poor outcome.2.4. High and low density lipoproteins (HDL and LDL)
HDL and other plasma lipoproteins can bind and neutralize
the bioactivity of Gram-negative bacterial LPS and Gram-po-
sitive bacterial LTA. During sepsis, circulating levels of HDL
decline dramatically. Although it is unclear how the loss of
HDL impacts inﬂammation and immune response, it is gener-
ally believed that the low levels of HDL impair the host’s abil-
ity to neutralize LPS. However, when HDL levels decline in
critically ill patients, LPS has been shown to bind preferen-
tially to LDL and VLDL that maintain their ability to neutral-
ize endotoxin [18]. In addition, the inhibitory eﬀect of HDL is
not always found, and this lipoprotein may also show pro-
inﬂammatory properties. A recent study has shown that native
HDL may in fact enhance monocyte response to LPS [28]. This
enhancing eﬀect was found in the presence of inhibitory con-
centrations of LPS-binding protein (LBP). This activity
appeared to be due to the ability of native HDL to suppress
the inhibitory activity of LBP. In contrast to native HDL,
LDL and reconstituted HDL did not possess this activity.2.5. Acute phase proteins
The circulating levels of many acute phase proteins (e.g. ser-
um amyloid proteins, ferritin, mannose-binding protein, a2-
macroglobulin), and the expression of coagulation factors
(ﬁbrinogen, plasminogen, thrombin, tissue factor) are en-
hanced during sepsis and SIRS. We will limit our discussion
to the most ‘‘popular’’ acute phase protein, namely C-reactive
protein and to LBP for its speciﬁc relevance to interact with
endotoxin during sepsis.
C-reactive protein (CRP) is an acute phase protein, member
of the pentraxin family, and produced by the liver. The pent-
raxins are found across invertebrate and vertebrate species
and share a cyclic pentameric structure resistant to heat and
proteases. CRP can bind to phosphocholine moieties and other
ligands in a calcium-dependent manner. By interacting with
polysaccharides and glycolipids on bacterial damaged mem-
branes and exposed nuclear antigens, CRP induces the binding
of C1q and the activation of the classical complement cascade.
CRP has also been shown to bind to the Fc receptors and to
enhance phagocytosis of microorganisms and cytokine pro-
duction. Interestingly, CRP is not an acute phase protein in
mice. However, CRP transgenic mice over-expressing rabbit
CRP are protected against endotoxic shock [29]. CRP is
mostly used to diagnose inﬂammation, as its levels rise dramat-
ically during inﬂammatory processes, such as inﬂammatory
bowel disease and some forms of arthritis, autoimmune dis-
eases, myocardial infarction, atherosclerosis, and cardiovascu-
lar diseases. CRP levels were also found increased after major
surgery and ischemia-reperfusion. The monitoring of CRP is
often used in patients after surgery or other invasive proce-
dures to detect the presence of an infection during the recovery
period. Indeed, CRP concentration was found to be consider-
ably increased during bacterial infection [30]. Thus, CRP is a
multifunctional protein playing a role in inﬂammation and
host defense.
LBP is present at homeostasis in the plasma, but its levels
are considerably increased during sepsis [31]. This protein is
mostly produced by the liver. In a concentration-dependent
manner, LBP can potentiate cell response by favoring the
interaction of LPS with the membrane form of CD14. Inver-
sely, at high concentrations, it will inhibit cellular response,
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important role in the lungs in response to LPS administration
or bacterial infection. Lung epithelial cells have been reported
to produce LBP in vitro, and pneumonia was associated with
an increase of LBP concentrations in the bronchoalveolar la-
vage ﬂuids of infected animals [33]. Furthermore, LBP knock-
out mice are more sensitive to the intranasal administration of
high doses of LPS, and show an impaired defense against
pneumonia, and intraperitoneal infections caused by Gram-
negative bacteria [33]. This impaired host defense seems to
be due to a delay in the inﬂammatory response and neutrophil
recruitment on the site of infection. However, during i.v. injec-
tion of LPS, the absence of LBP did not have an impact on the
in vivo inﬂammatory response of deﬁcient mice [34]. This is
probably due to the presence in the blood of other molecules
(such as sCD14) having a role similar to that of LBP, and
permitting an eﬃcient cellular response to LPS.2.6. Circulating endotoxin and markers of infection
It is worth mentioning that many of the severe insults that
require admission of patients to ICU are associated with the
presence of detectable amounts of endotoxin within the blood
stream, independent of any infection. For example, plasma
endotoxin has been found in 92% of the patients after cardiac
surgery with cardio-pulmonary bypass, in 71% of the patients
undergoing abdominal aortic surgery after clamp release, in
61% of the burn and trauma patients, in 57% of critically ill
ICU patients, and in 46% of patients resuscitated after cardiac
arrest [35]. The biological relevance of these levels of circulat-
ing endotoxin has been shown in diﬀerent clinical settings. In
resuscitated patients after cardiac arrest, the levels of circulat-
ing IL-6, IL-10 and IL-1 receptor antagonist (IL-1Ra) were
higher among the patients with detectable circulating endo-
toxin [24]. In meningococcal disease, the plasma levels of
LPS positively correlated with those of circulating chemokines
[36].
In addition to translocated endotoxin, it is obvious,
although poorly demonstrated, that other PAMPs can reach
the blood stream. For example, Shaw Warren’s group nicely
demonstrated that bacterial peptidoglycan-associated lipopro-
tein could be detected in the blood of mice that underwent
peritonitis [37]. Bacterial peptidoglycan has been detected in
the blood of rats after hemorrhagic shock [38], and it is most
probable that fragmented bacterial DNA could also be found
in the blood compartment. This has recently been illustrated
with the registration of the ‘‘Septifast’’ test that detects by
polymerase chain reaction analysis the presence of bacterial
or fungal DNA in blood: positive tests exceed positive blood
cultures.
Failure of the gut barrier remains central to the hypothesis
that endotoxin reaches systemic circulation via the portal route
or via lymphatic vessels. Endotoxins escaping from the gut lu-
men contribute to activation of the host’s inﬂammatory mech-
anisms, leading subsequently to tissue injury and multiple
organ failure (MOF). In addition, local activation of the im-
mune inﬂammatory system occurs, accompanied by a local
production of cytokines and other immune inﬂammatory
mediators [39]. These intestinal-derived mediators may result
in a further exacerbation of the systemic inﬂammatory re-
sponse. As stated by Swank and Deitch [40], ‘‘even if the im-
mune inﬂammatory system, rather than the gut, is the‘‘motor of’’ MOF, the gut remains one of the major pistons
that turns the motor’’.
The plasma level of procalcitonin (PCT), the precursor of
calcitonin, has been claimed to help to discriminate between
infection and inﬂammation, to identify the occurrence of an
infectious episode in critically ill patients, and to correlate with
organ failure and mortality. However, other data have chal-
lenged the speciﬁcity of plasma PCT elevation as a marker
for infection. In a recent review, it was suggested that the
dynamics of PCT levels, rather than the absolute values, could
be important in identifying patients with infectious compli-
cation after cardiac surgery [41]: PCT appears superior to
C-reactive protein (CRP) in discriminating infections, and
PCT levels increase markedly after bacterial and fungal infec-
tions, correlating with the severity of sepsis. As mentioned
earlier sTREM-1 was also believed to be a good marker for
bacterial infection, before high plasma levels were reported
in non-infectious SIRS patients.3. Cellular markers of stress
3.1. Nuclear and cytoplasmic markers
High-mobility group box-1 protein (HMGB-1) is a highly
conserved (>95% identity between rodent and humans) nuclear
protein that binds to cruciform DNA. It exists in a membrane
(‘‘amphoterin’’) and an extracellular form which interacts with
plasminogen and tissue type plasminogen activator. HMGB-1
is released during sepsis and found in plasma. Higher levels are
found among non-surviving patients [42]. It acts as an internal
danger signal molecule or ‘‘alarmin’’. HMGB-1 is a late medi-
ator of sepsis, it behaves like a cytokine, and stimulates the re-
lease of numerous pro-inﬂammatory cytokines by human
monocytes, although this property has been recently ques-
tioned. Anti-HMGB-1 antibodies protect mice against sepsis
even when delivered 24 h after the induction of sepsis (CLP
model) [43]. Like endotoxin, it activates leukocytes through
TLR4 as elegantly demonstrated in a model of liver ischemia
reperfusion performed in wild-type and TLR4 knockout mice
[44]. HMGB-1 also contributes to the ileal mucosal hyperper-
meability in a model of hemorrhagic shock as demonstrated by
the protective eﬀect of anti-HMGB-1 antibodies [45].
Most interestingly, HMGB-1 seems to be the mediator that
links during sepsis the occurrence of apoptosis and lethality
[46]. Beneﬁcial eﬀects obtained in sepsis with drugs such as
ethyl pyruvate are associated with a decreased expression of
HMGB-1 [47].
Heat shock proteins (HSPs) are other ‘‘alarmins’’ released in
diﬀerent stressful situations (sepsis, trauma, major surgery,
burns). As illustrated in Fig. 2, and in agreement with the lit-
erature, high levels of HSP70 were found in sepsis patients but
signiﬁcantly elevated levels were also found in brain death pa-
tients and in resuscitated cardiac arrest patients. In the latter
group, levels were similar among survivors and patients who
died after neurologic disorders, whereas signiﬁcantly higher
levels were measured in patients who died of a refractory
shock. In these patients a correlation between HSP70 and
endotoxin, IL-6, IL-8, sTREM-1 or soluble TNF receptor
were observed. There was no correlation either with IL-10, lac-
tates, clinical score (SAPS II), or the occurrence of infection.
A lot of properties were attributed to HSP before it was real-
ized that most were probably due to endotoxin contamination.
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Fig. 2. Plasma levels of HSP70 in sepsis and SIRS patients. (A) Levels of heat shock protein 70 (HSP-70) measured by speciﬁc ELISA (Stressgen) in
plasma of healthy controls (n = 15), resuscitated patients after cardiac arrest (RCA, n = 32), sepsis patients (n = 4) and brain death patients (n = 11).
In RCA patients, HSP70 levels correlated with plasma levels of LPS (r = 0.66, P = 0.01), IL-6 (r = 0.80, P < 0.0001), IL-8 (r = 0.9, P < 0.0001),
sTREM-1 (r = 0.87, P < 0.0001) and sTNFR (r = 0.68, P < 0.0001). (B) Levels of HSP70 in the plasma of RCA patients as a function of outcome.
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confer protection against ARDS, ischemia-reperfusion injury,
and sepsis-induced lung injury. HSPs seem to dampen the
inﬂammatory process as illustrated by the inhibition of LPS-
induced cytokine production in human monocytes over-
expressing HSP70 [48].
S100 proteins are small molecular size calcium-binding pro-
teins. More than 20 members of this protein family have been
described but three of them (S100A8, S100A9, and S100A12)
are speciﬁcally linked to innate immune functions by their
expression in the cytoplasm of phagocytes. They are released
by phagocytes in response to cell stress. Some extracellular
functions are related to anti-infectious host defense mecha-
nisms, but the main characteristics of the phagocyte-speciﬁc
S100 proteins are related to pro-inﬂammatory mechanisms.
S100A8, and S100A9 induce a thrombogenic and inﬂamma-
tory response in human endothelial cells. In addition, they in-
duce a number of pro-inﬂammatory chemokines, as well as
adhesion molecules like VCAM-1 and ICAM-1. They are sig-
niﬁcantly overexpressed at sites of inﬂammation, and there is a
strong correlation between their serum concentrations and
inﬂammation [49].
Monosodium urate crystals were recently identiﬁed as a
‘‘danger signal’ released from dying cells. It was shown that
the molecular mechanisms underlying monosodium urate crys-
tals-induced inﬂammation engage the caspase-1-activating
NALP3 inﬂammasome, resulting in the production of active
IL-1b and IL-18 [50].
3.2. Cell surface markers on monocytes
In addition to the quantiﬁcation of circulating cytokines or
soluble molecules, immunodysregulation in sepsis or SIRS
may be monitored by analyzing the expression of some cell
surface molecules. Human leukocyte antigen-DR (HLA-DR)
is one of these molecules. A profound decrease in its surface
expression on monocytes has been regularly reported in sepsis.
Low HLA-DR expression was associated with an increased
risk of secondary bacterial infections [51], probably due to a
less potent antigen presentation that would not allow an eﬃ-
cient adaptive immunity. The down-regulation of HLA-DR
is at least partially mediated by the immunosuppressive cyto-kine IL-10 which was shown to favor the intracellular seques-
tration of this major histocompatibility complex type II
molecule in human monocytes [52]. HLA-DR down-regulation
was also observed in monocytes of patients with a non-infec-
tious systemic inﬂammation, such as after pancreatitis, major
surgery or trauma. We studied the expression of HLA-DR
on monocytes from major trauma patients. Similarly to previ-
ous studies, we found a profound reduction of both the percent
of HLA-DR positive monocytes and of the mean ﬂuorescence
intensity for trauma patients as compared to healthy volun-
teers (Fig. 3A and B) [53].
In addition to HLA-DR, we analyzed the expression of the
membrane form of the pro-inﬂammatory cytokine IL-15. IL-
15 shares with IL-2 several biological eﬀects and IL-2 receptor
b and c chains. In contrast to IL-2 which is mainly produced
by activated T cells, IL-15 is produced by a variety of tissues,
including macrophages, dendritic cells, T-lymphocytes, or skel-
etal muscle. It is active on various cell types, including T and B
lymphocytes, natural killer cells or neutrophils. IL-15 plays an
important role in the development of natural killer cells and
the production of IFNc. The membrane form of IL-15 is found
on normal monocytes and is able to stimulate T lymphocytes
in vitro [54]. After ligation, membrane IL-15 may also induce
a reverse signaling into the monocytes that results in the pro-
duction of pro-inﬂammatory cytokines [55]. Similarly to
HLA-DR, we found a decrease of the membrane form of IL-
15 on monocytes of trauma patients (Fig. 3C and D). This re-
duced IL-15 expression may contribute to the lower monocyte
and T cell pro-inﬂammatory response found in these patients.
In contrast to the membrane form, circulating IL-15 was found
to be increased in patients with severe melioidosis [56]. IL-15
levels were also increased in the serum of ARDS patients
and correlated with poor outcome [57]. The latter observation
contrasts with data obtained with mice transgenic for IL-15,
that were found to be protected against a shock induced by
E. coli infection [58]. In this animal model, the protective eﬀect
of IL-15 was due to an impairment of apoptosis. Indeed, multi-
ple organ failure during sepsis is associated with an apoptotic
state of monocytes/macrophages and lymphocytes [59]. IL-15
is a potent inhibitor of apoptosis and when increased it may
protect against programmed cell death. However, at the same
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IL-12 and amplify the inﬂammatory response leading then to
organ failure and death [60]. It is not known whether there is
a relationship between the increase in the soluble form of IL-
15 and the decrease of its membrane form. Altogether, these
results suggest that IL-15 may be an important cytokine to
monitor during sepsis and severe inﬂammation. Although its
precise role has not been clearly deﬁned, IL-15 seems to be an-
other marker of stress-induced immune dysregulation in criti-
cally ill patients.
TREM-1 is a receptor selectively expressed on monocytes/
macrophages and neutrophils. TREM-1 belongs to the immu-
noglobulin superfamily, and consists of a single variable-type
immunoglobulin domain ectodomain, a transmembrane do-
main and a short cytoplasmic tail. This cytoplasmic tail does
not signal by itself, TREM-1 signaling needs the cooperation
of the adapter molecule DAP12. The ligand of TREM-1 is still
unknown but TREM-1 cross-linking with antibodies delivers a
pro-inﬂammatory signal to the cell and synergizes with diﬀer-
ent bacterial products such as LPS or muramyldipeptide for
pro-inﬂammatory cytokine production [61,62]. TREM-1
expression is increased on human monocytes upon LPS stimu-lation in vitro and blockade of TREM-1 protects mice against
endotoxin shock [61]. As discussed above, this molecule also
exists as a soluble form. The origin of this soluble form is
not clearly deﬁned. It may result from the proteolytic cleavage
of the membrane form or be generated from an alternative
splicing of the TREM-1 mRNA. Upon LPS injection in
healthy volunteers, TREM-1 surface expression was found to
be decreased on neutrophils, whereas it was increased on circu-
lating monocytes [23]. In human sepsis, an increase of TREM-
1 was found on patients circulating monocytes, but no change
was noticed on neutrophils [63]. A slightly diﬀerent result was
found in a CLP mouse model of sepsis. In this model, TREM-
1 surface expression was ampliﬁed for both circulating mono-
cytes and neutrophils, as well as on macrophages and
neutrophils present in the peritoneal cavity [63]. Thus, while
it seems clear that LPS or bacterial infection result in an
increased expression of TREM-1 on monocytes, the conse-
quences for neutrophils seem less clear-cut. Very little is known
about TREM-1 expression on monocytes during non-infec-
tious severe inﬂammation. There is one study reporting an
up-regulation of TREM-1 on patients’ monocytes after major
abdominal surgery [64].
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are found in large amounts in the plasma of sepsis and criti-
cally ill patients. These markers are danger signals delivered
by the microorganisms and share many properties with inter-
nal danger signals (alarmins). For most of the stress proteins,
their plasma levels correlate with severity and clinical scoring.
In sepsis and SIRS, an exacerbated production of these medi-
ators contributes to tissue damage, organ injury, alteration of
the immune system, and eventually death. As recently demon-
strated by Tang et al. about procalcitonin [65], a given marker
can be appreciated for a while and dismissed later on. So far,
IL-6 and surface HLA-DR expression are probably the best
markers of the severity of the inﬂammatory process and of
the altered immune status, respectively. However, they do
not allow to discriminate between severe infection and sys-
temic inﬂammation.
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